Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Cariou, B., Hadjadj, S., Wargny, M. et al.
Diabetologia. 2020 May 29;1-16.
http://www.doi.org/10.1007/s00125-020-05180-x
Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA 1c, in Patients With Type 2 Diabetes
Ali A, Martinez R, Al-Jobori H, Adams J, Triplitt C, DeFronzo R, et al.
Diabetes Care 2020 Jun;43(6):1234-1241.
http://www.doi.org/10.2337/dc18-2460
Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Braffett BH, Gubitosi-Klug RA, Albers JW, et al.; DCCT/EDIC Research Group.
Diabetes. 2020 May;69(5):1000-1010.
http://www.doi.org/10.2337/db19-1046
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
Drucker DJ
Endocr Rev. 2020 Jun 1;41(3).
http://www.doi.org/10.1210/endrev/bnaa011
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9).
Lane WS, Favaro E, Rathor N, Jang HC, et al.
Diabetes Care. 2020 Mar 24.
http://doi.org/10.2337/dc19-2232
The changing face of paediatric diabetes.
Shah AS, Nadeau KJ.
Diabetologia. 2020 Apr;63(4):683-691.
http://doi.org/10.1007/s00125-019-05075-6
Comentarios recientes